Researchers found that lowering MHC I can expose cancerous or foreign cells to CD4+ T cell attack, reshaping assumptions ...
Researchers have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity. The pre-clinical findings highlight the potential to ...
For decades, HIV treatment has depended on one hard truth: once medication stops, the virus usually comes roaring back. Modern antiretroviral drugs can suppress HIV so effectively that many people ...
Persistent viral infections pose a unique challenge to the immune system. Prolonged antigen exposure drives T cells into a state of exhaustion — a ...
Brii Bio has presented final results from its Phase 2 ENSURE study at the EASL Congress 2026, showing that the addition of ...
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved ...
Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate ...
In this study, researchers evaluated the safety, immunogenicity, and preliminary clinical activity of GNOS-PV01 monotherapy in MGMT-unmethylated glioblastoma.
mNational Institute for Health Research National Commercial Research Delivery Centre, Bradford, UK nNational Institute for Health Research Manchester Biomedical Research Centre, Manchester University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results